NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.190
+0.030 (2.59%)
Nov 18, 2026, 4:00 PM EST - Market closed
NanoViricides Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 2.58 | 2.79 | 1.56 | 4.8 | 8.15 | 14.07 |
Cash & Short-Term Investments | 2.58 | 2.79 | 1.56 | 4.8 | 8.15 | 14.07 |
Cash Growth | 128.76% | 79.27% | -67.52% | -41.13% | -42.06% | -31.44% |
Prepaid Expenses | 0.41 | 0.37 | 0.11 | 0.17 | 0.3 | 0.35 |
Total Current Assets | 2.98 | 3.16 | 1.67 | 4.97 | 8.45 | 14.42 |
Property, Plant & Equipment | 6.28 | 6.4 | 6.83 | 7.51 | 8.11 | 8.69 |
Other Intangible Assets | 0.31 | 0.31 | 0.32 | 0.33 | 0.33 | 0.34 |
Other Long-Term Assets | 0 | 0 | 0 | 0.01 | 0.01 | 0.04 |
Total Assets | 9.56 | 9.87 | 8.82 | 12.82 | 16.9 | 23.49 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 0.53 | 0.32 | 0.46 | 0.38 | 0.16 | 0.06 |
Accrued Expenses | 1.92 | 0.04 | 0.03 | 0.26 | 0.14 | 0.05 |
Short-Term Debt | - | - | - | - | - | 0.09 |
Other Current Liabilities | 0.7 | 0.83 | 0.82 | 0.72 | 0.23 | 0.21 |
Total Current Liabilities | 3.15 | 1.19 | 1.31 | 1.36 | 0.53 | 0.41 |
Other Long-Term Liabilities | - | - | - | - | 1.5 | - |
Total Liabilities | 3.15 | 1.19 | 1.31 | 1.36 | 2.03 | 0.41 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 169.22 | 165.74 | 156.36 | 150.84 | 145.95 | 145.57 |
Retained Earnings | -162.8 | -157.06 | -148.84 | -139.37 | -131.08 | -122.49 |
Total Common Equity | 6.41 | 8.68 | 7.52 | 11.46 | 14.87 | 23.08 |
Shareholders' Equity | 6.41 | 8.68 | 7.52 | 11.46 | 14.87 | 23.08 |
Total Liabilities & Equity | 9.56 | 9.87 | 8.82 | 12.82 | 16.9 | 23.49 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | - | - | - | - | - | 0.09 |
Net Cash (Debt) | 2.58 | 2.79 | 1.56 | 4.8 | 8.15 | 13.97 |
Net Cash Growth | 128.76% | 79.27% | -67.52% | -41.13% | -41.67% | -31.58% |
Net Cash Per Share | 0.12 | 0.14 | 0.10 | 0.40 | 0.70 | 1.21 |
Filing Date Shares Outstanding | 25.56 | 25.53 | 17.43 | 14.68 | 11.75 | 11.59 |
Total Common Shares Outstanding | 25.55 | 23.01 | 16.61 | 13.14 | 11.7 | 11.59 |
Working Capital | -0.17 | 1.97 | 0.36 | 3.61 | 7.91 | 14 |
Book Value Per Share | 0.25 | 0.38 | 0.45 | 0.87 | 1.27 | 1.99 |
Tangible Book Value | 6.11 | 8.37 | 7.2 | 11.14 | 14.53 | 22.74 |
Tangible Book Value Per Share | 0.24 | 0.36 | 0.43 | 0.85 | 1.24 | 1.96 |
Land | - | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 |
Machinery | - | 6.2 | 6.6 | 6.54 | 6.38 | 6.25 |